Cash Flow Statement
Growth Metrics

Harvard Bioscience (HBIO) EBIT Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Growth (1y) (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn 47.95%
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn -75.72%
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn 17.25%
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn 65.51%
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn -
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn 16.92%
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn 8.28%
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn 13.79%
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn -5.25%
10 Harvard Bioscience 25.38 Mn 18.29 Mn 12.24 Mn 97.64%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 97.64%
Dec 31, 2025 916.09%
Sep 30, 2025 110.51%
Jun 30, 2025 60.42%
Mar 31, 2025 -2,079.38%
Dec 31, 2024 275.52%
Sep 30, 2024 -100.86%
Jun 30, 2024 -359.92%
Mar 31, 2024 -230.30%
Dec 31, 2023 -147.24%
Sep 30, 2023 75.20%
Jun 30, 2023 -80.09%
Mar 31, 2023 126.06%
Dec 31, 2022 167.75%
Sep 30, 2022 -786.50%
Jun 30, 2022 6,793.10%
Mar 31, 2022 -2,708.37%
Dec 31, 2021 69.22%
Sep 30, 2021 201.10%
Jun 30, 2021 -89.57%
Mar 31, 2021 92.70%
Dec 31, 2020 -38.52%
Sep 30, 2020 113.33%
Jun 30, 2020 143.86%
Mar 31, 2020 -2,627.50%
Dec 31, 2019 -6.26%
Sep 30, 2019 -253.37%
Jun 30, 2019 159.69%
Mar 31, 2019 90.52%
Dec 31, 2018 365.78%
Sep 30, 2018 328.21%
Jun 30, 2018 -42.01%
Mar 31, 2018 -261.71%
Dec 31, 2017 133.30%
Sep 30, 2017 52.03%
Jun 30, 2017 67.98%
Mar 31, 2017 -58.37%
Dec 31, 2016 -1,093.81%
Sep 30, 2016 -4.90%
Jun 30, 2016 -948.48%
Mar 31, 2016 80.78%
Dec 31, 2015 -94.67%
Sep 30, 2015 -154.39%
Jun 30, 2015 -94.30%
Mar 31, 2015 -186.21%
Dec 31, 2014 323.50%
Sep 30, 2014 244.20%
Jun 30, 2014 132.98%
Mar 31, 2014 0.60%
Dec 31, 2013 -144.39%
Sep 30, 2013 -64.19%
Jun 30, 2013 -69.85%
Mar 31, 2013 -35.69%
Dec 31, 2012 54.03%
Sep 30, 2012 425.45%
Jun 30, 2012 -1.79%
Mar 31, 2012 5.74%
Dec 31, 2011 -52.60%
Sep 30, 2011 -88.68%
Jun 30, 2011 6.20%